130 related articles for article (PubMed ID: 26166578)
1. Targeting AMPK signalling pathway with natural medicines for atherosclerosis therapy: an integration of in silico screening and in vitro assay.
Ou T; Hou X; Guan S; Dai J; Han W; Li R; Wang W; Qu X; Zhang M
Nat Prod Res; 2016 Jun; 30(11):1240-7. PubMed ID: 26166578
[TBL] [Abstract][Full Text] [Related]
2. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
[TBL] [Abstract][Full Text] [Related]
3. Stepwise high-throughput virtual screening of Rho kinase inhibitors from natural product library and potential therapeutics for pulmonary hypertension.
Su H; Yan J; Xu J; Fan XZ; Sun XL; Chen KY
Pharm Biol; 2015 Aug; 53(8):1201-6. PubMed ID: 25853972
[TBL] [Abstract][Full Text] [Related]
4. Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.
Mahajan P; Wadhwa B; Barik MR; Malik F; Nargotra A
Mol Divers; 2020 Feb; 24(1):45-60. PubMed ID: 30798436
[TBL] [Abstract][Full Text] [Related]
5. AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.
Dite TA; Langendorf CG; Hoque A; Galic S; Rebello RJ; Ovens AJ; Lindqvist LM; Ngoei KRW; Ling NXY; Furic L; Kemp BE; Scott JW; Oakhill JS
J Biol Chem; 2018 Jun; 293(23):8874-8885. PubMed ID: 29695504
[TBL] [Abstract][Full Text] [Related]
6. Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products.
Xu G; Huang K; Zhou J
Curr Med Chem; 2018; 25(8):889-907. PubMed ID: 28393690
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design.
Miglianico M; Nicolaes GA; Neumann D
J Med Chem; 2016 Apr; 59(7):2879-93. PubMed ID: 26510622
[TBL] [Abstract][Full Text] [Related]
8. Integrated discovery of FOXO1-DNA stabilizers from marine natural products to restore chemosensitivity to anti-EGFR-based therapy for metastatic lung cancer.
Sun Y; Ai X; Hou J; Ye X; Liu R; Shen S; Li Z; Lu S
Mol Biosyst; 2017 Jan; 13(2):330-337. PubMed ID: 27966721
[TBL] [Abstract][Full Text] [Related]
9. Structure-based grafting and identification of kinase-inhibitors to target mTOR signaling pathway as potential therapeutics for glioblastoma.
Cui YH; Chen J; Xu T; Tian HL
Comput Biol Chem; 2015 Feb; 54():57-65. PubMed ID: 25625417
[TBL] [Abstract][Full Text] [Related]
10. Introducing a simple model system for binding studies of known and novel inhibitors of AMPK: a therapeutic target for prostate cancer.
Kumar R; Maurya R; Saran S
J Biomol Struct Dyn; 2019 Feb; 37(3):781-795. PubMed ID: 29447108
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.
Ebrahim HY; El Sayed KA
Mar Drugs; 2016 Mar; 14(3):. PubMed ID: 26978377
[TBL] [Abstract][Full Text] [Related]
12. Identifying New AMP-Activated Protein Kinase Inhibitors That Protect against Ischemic Brain Injury.
Eom JW; Kim TY; Seo BR; Park H; Koh JY; Kim YH
ACS Chem Neurosci; 2019 May; 10(5):2345-2354. PubMed ID: 30763060
[TBL] [Abstract][Full Text] [Related]
13. Structure-based modelling, scoring, screening, and in vitro kinase assay of anesthetic pkc inhibitors against a natural medicine library.
Shi BX; Chen FR; Sun X
SAR QSAR Environ Res; 2017 Feb; 28(2):151-163. PubMed ID: 28235389
[TBL] [Abstract][Full Text] [Related]
14. In silico Analysis of AMP-activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators.
Ghaffar A; Batool S; Mushtaq G; Kamal MA
Curr Comput Aided Drug Des; 2017; 13(3):222-233. PubMed ID: 28294049
[TBL] [Abstract][Full Text] [Related]
15. Targeting of AMP-activated protein kinase: prospects for computer-aided drug design.
Kim J; Yang G; Ha J
Expert Opin Drug Discov; 2017 Jan; 12(1):47-59. PubMed ID: 27797589
[TBL] [Abstract][Full Text] [Related]
16. Consensus scoring approach to identify the inhibitors of AMP-activated protein kinase α2 with virtual screening.
Park H; Eom JW; Kim YH
J Chem Inf Model; 2014 Jul; 54(7):2139-46. PubMed ID: 24915156
[TBL] [Abstract][Full Text] [Related]
17. An Integrated In Silico Method to Discover Novel Rock1 Inhibitors: Multi- Complex-Based Pharmacophore, Molecular Dynamics Simulation and Hybrid Protocol Virtual Screening.
Chen H; Li S; Hu Y; Chen G; Jiang Q; Tong R; Zang Z; Cai L
Comb Chem High Throughput Screen; 2016; 19(1):36-50. PubMed ID: 26632439
[TBL] [Abstract][Full Text] [Related]
18. Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach.
Huang T; Sun J; Zhou S; Gao J; Liu Y
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28665353
[TBL] [Abstract][Full Text] [Related]
19. Integrated In Silico-In Vitro Discovery of Lung Cancer-related Tumor Pyruvate Kinase M2 (PKM2) Inhibitors.
Ye X; Sun Y; Xu Y; Chen Z; Lu S
Med Chem; 2016; 12(7):613-620. PubMed ID: 26951145
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
